LLY - Eli Lilly and Company 0 WATCHERS

NVDA, RDDT, VALE, LLY

I too sold LLY too soon.

So what’s your game plan for 2026? Man, I still can’t wrap my head around the fact that we’re like twenty something days away from 2026. This year just flew by and honestly, it was kinda wild in a good way. Hands down, my favorite move of the year was …

why is LLY getting smacked?

Lol I sold LLY at 716 because the price dropped and I got nervous. I would be independently wealthy right now

You ride the same stock for decades you have insanely high gain. I have relatives who had LLY,JNJ,XOM since the early 90s- they did very well just get some big mega company like that and sit on it forever.

Big LLY down another almost 2%, lmao. Holy profit taking, Batman. Down $83 over the last 5 trading days.

Love reading about people deleting ever more of their wealth dumping into nvo. Please, tell me more about why LLY won’t continue to completely dominate them for the next decade.

BASFY, but the whole sector is down due to overcapacity. Possibly RHHBY. They are trying to become GLP bros like LLY

Some hedge fund must've had it with the selling off of LLY all day. Last 3 minutes straight up $6 from the day's low.

MA, AXP, BRKB, RTX, UNH, CNC, ALL, BLK, BA, LMT, BP, CAT, BROS, DIS, IBM, MRK, LLY, NFLX, PLD, WELL,and WRB. List goes on, boring and consistent for the majority.

$LLY

LLY. I bought it when it tanked but it quickly shot up to 850. Eventually it went down to the low 700s and I decided I didn't want to risk it. Now look...... I'm such an idiot

I don't regret any tbh. You cannot time or predict the market. I did recently buy LLY in the $600s and sold it in the $800s. Now it is over $1,000. But I do not regret selling it.

“AI Winners Basket” includes NVDA (not covered), GOOGL, MSFT, AMZN, META, AVGO (not covered), TSMC (not covered), ORCL, PLTR, AMD (not covered), MU (not covered), & IBM (we exclude major nonAI outperformers like AAPL, TSLA, & LLY). This basket added ~$15T in market cap (~$14T ex-TSMC) since the launch of …

NVO & LLY: GLP-1 hype train just hit its first real speed bump. https://www.smh.com.au/healthcare/watchdog-issues-safety-alert-for-ozempic-and-other-glp-1-drugs-20251201-p5njus.html Australia’s TGA updated safety warnings for Ozempic/Wegovy/Mounjaro to include potential suicidal thoughts, even though they admit there’s no proof the drugs cause it. Bad headlines move markets. GLP-1 stocks (NVO, LLY) have been priced like they …

Bro, That is very common issue for everyone. When UNH was low, I bought 25 shares at $240, never knew about Berkshire stake at that time. Same way when CRWV was IPOed, I bought 25 shares of CRWV at $37.5. Sameway, bought 5 LLY at $625. Now, hindsight I regret …

LLY

Eli Lilli (LLY) Im suprised no one's said this one, because glp 1 agonists (weight lose drugs) i.e. Ozempic and retatrutide are on the rise. I reckon especially with the early human trials of reta only just recently being undertaken with the release of reta theirs going to be massive …

Parallel/Analogue of Dot Com bubble, fed rat cuts, melting up, and thesis for big pharma and managed care (didn't happen, I ran out of space). For those who lack reading comprehension, I’m saying that the market will melt up, not crash immediately. Before I start, I just want to acknowledge …

Did LLY 6months ago, having my eyes on NVO now, still reluctant: - end of IP protection in several countries - growing competition - cost problem - only bad news recently Waiting for convincing news / facts.

I put $10k into LLY this year. Up way too much. It'll split and keep going too...sorry I get the NVO value case but it's like comparing NVDA to INTC

Eli Lilly just hit a $1T market cap first pharma company ever to do it Crazy to think a drugmaker has now joined the trillion-dollar club. LLY’s rise has been unbelievable obesity drugs, Alzheimer’s treatment, you name it. Feels like investors are finally treating “health tech” the same way they …

Stop - enough already - there are tons of bio plays out there and if you choose to play that game you are accepting very high risk for \*\*potential\*\* high reward. If you did not make great gains off LLY, well you missed that boat(there will be more). If you …

LLY is likely going to win the oral glp1 race, especially because their version doesn’t require you to fast like Novo’s does lol

I’ve heard so much crying over NVO. And I must be honest. I’ve been entertained. The added value of running up NVO and sharing results here has brought me the conviction I needed to buy. I’ve been running good lately. Getting lucky. Can’t wait to be back here and share …

LLY reaching ATH while NVO sitting at levels it was half a decade ago. Cope, lol.

I invested in LLY to hedge my investment in NVO, was a good decision….

NOOO!!! $NVO DOWN 10% IN A DAY Oh. Sorry I misread.. that was 2 days ago.. now it’s back at the same level as last week. Let’s be real anyone thinking that Novo is not getting out of this slump eventually is too emotional: - cash cow with massive consistent …

JNJ is pivoting to become more akin to LLY. It isn’t a safety consumer stock like it was pre Kenvue sell off. The optics of that sell off from KMB’s perspective probably seem worse because of all the noise around Tylenol etc which RFK says causes the ‘tism. So, I’d …

Would it still be worth investing in LLY today, or is it too late right now?

Sure, after the Alzheimer trial didn’t show any promising results which resulted in the drop; buying a pharma company and betting its trial success or FDA approval is what you would call gambling, not investing; LLY is stealing their market share in both the diabetes and obesity treatment markets, plus …

I just don't know why people force themselves to buy NOVO. It is cheap for a reason. Classic value trap IMO. Look at MRK, REGN, etc. and what they've done lately. Great runs. This tells you it's not a sector problem- it's an individual company problem. LLY is up 34% …

Don’t kick yourself too much. There is always another opportunity, somewhere out there. FWIW, sold TSLA at $150 pre-split after reading comments here too. This was yonks ago. Realized then that, perhaps folks here might have hidden objectives. Problem with NVO is that it’s a one trick wonder. Was kinda …

Selling stock at profit is not a mistake! Similarly, I sold LLY upon the potential price drop rumor a couple months ago around 800-900 while knowing it can go above 1200. Still consider this a good move on my part and good exercise of caution! We shouldn't beat ourselves up …

MRK spent 20Y to make an ATH. I used to own the stock but somehow I’m numb seeing it climbing up recently. Congrats on LLY btw, im still holding my Mariana trenchonovo

Everyone talking about GOOG up $160 while LLY is up $500.

LLY up 80% since August in a straight line

Wtf is going on with LLY?? PE of 54 for a pharmaceutical company when Mango slashed the price on fatty meds by 80 fucking percent. How? The math does not math. Puts should 100% print next earnings report, but it's probably like tesla now only trading on vibes.

LLY going parabolic

In 2y I already have a 200% gain on it. If it drops to 100% gain in 3y, im still beating the SP500 over that 3y span (10& YoY avg, 6% if being conservative). Im gonna hold until I retire/die. Theres a few stocks I regret selling. $LLY being one …

LLY on an absolute tear. Up 75% since August…

Bruh I have a similar background as these so called doctors and pharmacists and I've honestly no idea what made them think NVO was a better play than LLY

I bought LLY in 2019 (<$200), sold it (\~$900) last year, and used the money to swap to NVO, MRK, PFE, BMY. In Sept I added some LLY back (\~$700). I added more NVO today and expect to add more as tax loss harvesting pushes it further down. I have …

LLY is the true value in the space

I bought LLY at $630 on AUG 7th very happy my only regret was not getting more

LLY is overvalued. NVO is significantly undervalued. The market has rewarded expensive stocks and sold off cheap stocks over the past six months. Just how it is during risk-on periods. What will you say when LLY falls 50%? Will you blame this subreddit too?

Bought LLY August 8th on the drop. Up 70% as of today on it

I own both. I’m considering selling out LLY here and going in heavier on NVO. It’s so beat down. And I’ll collect the 4% dividend while I wait.

Do you need money now? If yes, maybe it is a good time to shed some goog for profits. For NVO, fuck that shit.. Depends how much you have in it but there is an argument to just get rid of it. They keep fumbling their shit while LLY keep …

The most important pharma market is USmarket by far. Lilly is a US company. NVO is not a US company. Trump administration is protectionist. That was all you needed to know. Also: always inverse reddit. Disclosure: I worked in big pharma and knowing both companies pretty well I was very …

NVO will be $100 in less than 3 years. You should get decent returns depending on your entry point. Trump skewed the game a lot in LLY’s favour but NVO is still solid. Don’t judge your investments based on only 6 months but yeah the developments have not been great …

Eli Lilly (LLY) has a P/E of 50 that was around 100 this time last year. From February 2024 through October 2025, the share price was rangebound between $770 and $950. I bought Novo in 2024 instead of Lily because it seemed like the safer option, but it turned out …

People get caught up on p/e too much. Yes it does matter but there are reasons why something might be expensive just like there are reasons why something might be cheap. NVO is not some obscure mis priced gem that the market needs to find. They just aren’t executing. Pharma …

I’m long LLY. Never second-guess yourself. Research, buy in, HODL. Decades. F it. The good thing about not second-guessing yourself is if it all goes to crap, you know you can only blame yourself and not others for giving you their crap opinion.

Why would anyone invest in NVO when LLY has Retatrutide coming next year?

LLY the King ❤️❤️ bought at 652 ,sold at 1050. Best Pharma Stock overall

Soo glad I got out of this a few weeks ago at break even. Thought I was crazy for not getting out a few months ago when I was up 20%. My average was $48. LLY will always spank NVO

All the market moving news in premarket summarised in one short 5 minute report. MAG7: * GOOGL - AI infrastructure chief told employees the company now has to 2x compute capacity every 6months to keep up with demand, saying the next 1000x needs to happen in four to five years. …

Good thing I picked NVO instead of LLY! I almost made money there for a second…😨

All you had to do was to invest in LLY

The GLP1 is obviously a huge driver here but LLY also has some awesome stuff in the pipeline like their breast cancer and Alzheimer’s drugs. When it tanked after the $150 statement from the White House it was an absolute bargain going into earnings.

The trend has changed for Big Pharma - the market is getting more defensive Health care has been underperforming - its been [the worst performing sector in the last 5 years.](https://userupload.gurufocus.com/1992615725424091136.png) However the trend is now changing. Below is a table of the top-10 big Pharma Co's giving total return …

Some people will hate my strategy but it works for me as I retired early 12 years ago and been living the good life. One of the most important things in investing (not gambling) is to have both a downside and upside strategy. For my downside strategy, it is simple …

LLY + NVO mkt caps remained the same.

I remember staring at my LLY leap buy order when it dropped to 630 post earnings on great numbers and never executing them

LLY is a bubble. NVO is value. Sell LLY. Buy and hold NVO for next 5 years. Ill come back and comment here in 2030

Probably depends on LLY. But I heard LLY had the advantage, and LLY is doing quite good recently

It's simple When their competitor is booming and they're tanking, it's not "value" its a trap. Go look at LLY vs NVO 1 month.

can´t wait for the LLY x McD Crossover

Mango lowered the price on GLP1 drugs for obesity by 80% (from just six months ago). LLY Is extremely over valued at PE of 52. Their earnings and margins will take a massive hit and it will show in Q1 or Q2. They will need to 4-5x their sales, in …

LLY was under the radar for me since i avoid pharma stocks due to rug pulls. But i feel this and GOOG are currently safe stocks due to their steady gains in the past month Much better than other trillion dollar companies taking a big hit recently

Eli Lilly becomes the first pharma to hit a 1 trillion dollar market cap on booming weight loss drug demand. LLY is +30% over the past month No paywall: [https://www.investors.com/news/technology/eli-lilly-trillion-dollar-club-tech-companies/](https://www.investors.com/news/technology/eli-lilly-trillion-dollar-club-tech-companies/) >Eli Lilly (LLY) became the first health care company to top $1 trillion in market capitalization on Friday, joining an …

NVO+LLY mkt caps remained same lol.

LLY, CAT, PGR or ABBV…

IMO, LLY is overextended and riskier compared to other healthcare stocks. LLY knows how to market and communicate through the media to boost its share price, which is very different from NVO - NVO leadership doesn't know how to communicate positively in the media. LLY 1 Trillion is too high …

$NVO catalyst upcoming 1. FDA decision on their glp weight loss oral pill will be coming in Q4. This can be a FDA decision on their glp weight loss oral pill will be coming in Q4. This can be a huge catalyst for a rerating of the stock. They are …

Eli Lilly Becomes First Healthcare Company to Reach $1 Trillion Valuation Eli Lilly made history today by becoming the first pharmaceutical and healthcare company to reach a $1 trillion market capitalization, propelled by extraordinary global demand for its weight-loss drugs, including Mounjaro and Zepbound. The milestone positions Lilly alongside an …

Eli Lilly Becomes First Healthcare Company to Reach $1 Trillion Valuation Eli Lilly made history today by becoming the first pharmaceutical and healthcare company to reach a $1 trillion market capitalization, propelled by extraordinary global demand for its weight-loss drugs, including Mounjaro and Zepbound. The milestone positions Lilly alongside an …

LLY joined the trillion $ club.

GOOG LLY CLS MU MP

LLY about to be the next trillion $ company.

Eli Lilly obesity pipeline update As LLY hits ATH today, let's take a look at LLY's obesity pipeline after Q3 earnings. 1.) orforglipron: the development story is almost done, and the sales cycle is just about to start. we now know that LLY has applied for the priority voucher and …

Fidelity is the best broker. The reason you had a poor fill is because of low volume/open interest. Traded LLY and barely anyone to fill my calls. Had to manually set my fill order while Fidelity looks for the best buyer through different exchanges.

$TMO $PG $UNH $ALB $LLY

$AIRE AIRE Launches Internal AI-Powered Engagement Assistant to Automate Lead Management and Streamline Mortgage Workflow. The company today announced the launch of its internal AI-powered Engagement Assistant, a multi-agent system designed to handle top-of-the-funnel lead qualification, appointment booking, and other pre-application workflows, helping improve scalability and efficiency across mortgage operations. …

If its so cheap, why aren't insiders buying? When LLY dropped a few months ago irrationally, insiders bought the dip heavily

LY QuantSignals V3: This Stock Could Be Next Week's Big Mover (Full Analysis Inside) 📈 What if you could see next week's market moves today? Our latest QuantSignals V3 breakdown for LLY is live. We don't just show the signal—we show you the data behind it. This isn't guesswork; it's …

$VWAV VisionWave Expands IP Portfolio and Files Patent for WaveStrike — RF Computer-Vision Fire-Control Built for Real-World Combat Environments The company today announced the filing of U.S. Provisional Patent Application No. 63/892,721, titled “AI-Assisted Multi-Modal RF Fire-Control System for All-Domain Target Engagement.” The new application expands VisionWave’s Vision-RF patent portfolio …

Slightly off topic: When I was building a buy & hold portfolio I came across a list of Gates' portfolio purchases. I reviewed them all and picked out the ones I liked. Top performer is LLY which I got for around $40. I'm thinking Gates, at a minimum, double or …

Never sell LLY. You’ll thank me in a decade.

Generally to invest successfully in a niche field you have two choices - buy the large caps NOVO or LLY to get the market beta, or become an expert in the field either with through education, or as an external speculator. For me I choose option one, but option two …

My main concern with LLY is that a significant portion of its growth has been priced in already. But LLY stock has some recent history of oversized drawdowns that IMO are usually completely out of proportion to whatever news is fueling the drawdown. I'm always willing to scoop up shares …

I trimmed off some of my $LLY at $1026 and yes it was hard

I have a 2X leveraged LLY stock that I’m going to hold for a very long time

LLY doing just fine

Should I sell my Eli Lilly $LLY stock? Up 40% My cost basis is $727 and it’s at $1,026 right now. I could sell and get $1,800 of gain today (40% gains). Not sure if this company will go up a lot tho